{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:21:31Z","timestamp":1791390091546,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T00:00:00Z","timestamp":1068163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T00:00:00Z","timestamp":1068163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/ar1028","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T02:19:20Z","timestamp":1068776360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols"],"prefix":"10.1186","volume":"6","author":[{"given":"Eleni","family":"Douni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylva","family":"Haralambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kollias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,11,7]]},"reference":[{"key":"1019_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996, 14: 397-440. 10.1146\/annurev.immunol.14.1.397.","journal-title":"Annu Rev Immunol"},{"key":"1019_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00002281-200307000-00003","volume":"15","author":"PP Sfikakis","year":"2003","unstructured":"Sfikakis PP, Kollias G: Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol. 2003, 15: 380-386. 10.1097\/00002281-200307000-00003.","journal-title":"Curr Opin Rheumatol"},{"key":"1019_CR3","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G: Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991, 10: 4025-4031.","journal-title":"EMBO J"},{"key":"1019_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/eji.1830250647","volume":"25","author":"L Probert","year":"1995","unstructured":"Probert L, Plows D, Kontogeorgos G, Kollias G: The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol. 1995, 25: 1794-1797.","journal-title":"Eur J Immunol"},{"key":"1019_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/joca.1998.0201","volume":"7","author":"M Yaron","year":"1999","unstructured":"Yaron M, Shirazi I, Yaron I: Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage. 1999, 7: 272-280. 10.1053\/joca.1998.0201.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/joca.1999.0289","volume":"8","author":"F Moldovan","year":"2000","unstructured":"Moldovan F, Pelletier JP, Jolicoeur FC, Cloutier JM, Martel-Pelletier J: Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage. 2000, 8: 186-196. 10.1053\/joca.1999.0289.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR7","first-page":"2417","volume":"25","author":"JP Pelletier","year":"1998","unstructured":"Pelletier JP, Mineau F, Fernandes JC, Duval N, Martel-Pelletier J: Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol. 1998, 25: 2417-2424.","journal-title":"J Rheumatol"},{"key":"1019_CR8","first-page":"753","volume":"25","author":"J Martel-Pelletier","year":"1998","unstructured":"Martel-Pelletier J, Mineau F, Jolicoeur FC, Cloutier JM, Pelletier JP: In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol. 1998, 25: 753-762.","journal-title":"J Rheumatol"},{"key":"1019_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/joca.1997.0088","volume":"6","author":"AR Moore","year":"1998","unstructured":"Moore AR, Greenslade KJ, Alam CA, Willoughby DA: Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. Osteoarthritis Cartilage. 1998, 6: 19-23. 10.1053\/joca.1997.0088.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR10","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P","volume":"43","author":"JP Pelletier","year":"2000","unstructured":"Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD: Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum. 2000, 43: 2339-2348. 10.1002\/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P.","journal-title":"Arthritis Rheum"},{"key":"1019_CR11","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T","volume":"44","author":"M Dougados","year":"2001","unstructured":"Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M: Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip. Arthritis Rheum. 2001, 44: 2539-2547. 10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"key":"1019_CR12","first-page":"S31","volume":"Suppl","author":"M Lequesne","year":"1998","unstructured":"Lequesne M, Berdah L, Gerentes I: Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis [in French]. Rev Prat. 1998, Suppl: S31-S35.","journal-title":"Rev Prat"},{"key":"1019_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/1529-0131(199904)42:3<545::AID-ANR20>3.0.CO;2-4","volume":"42","author":"GN Smith Jr","year":"1999","unstructured":"Smith GN, Myers SL, Brandt KD, Mickler EA, Albrecht ME: Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum. 1999, 42: 545-554. 10.1002\/1529-0131(199904)42:3<545::AID-ANR20>3.0.CO;2-4.","journal-title":"Arthritis Rheum"},{"key":"1019_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1063-4584(05)80103-7","volume":"4","author":"SL Carney","year":"1996","unstructured":"Carney SL: Effect of diacetyl rhein on the development of experimental osteoarthritis. A biochemical investigation. Osteoarthritis Cartilage. 1996, 4: 251-261.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1063-4584(97)80048-9","volume":"5","author":"KD Brandt","year":"1997","unstructured":"Brandt KD, Smith G, Kang SY, Myers S, O'Connor B, Albrecht M: Effects of diacerhein in an accelerated canine model of osteoarthritis. Osteoarthritis Cartilage. 1997, 5: 438-449.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1053\/joca.1999.0257","volume":"7","author":"T Tamura","year":"1999","unstructured":"Tamura T, Ohmori K, Nakamura K: Effect of diacerein on spontaneous polyarthritis in male New Zealand black\/KN mice. Osteoarthritis Cartilage. 1999, 7: 533-538. 10.1053\/joca.1999.0257.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/ar419","volume":"4","author":"ES Chan","year":"2002","unstructured":"Chan ES, Cronstein BN: Molecular action of methotrexate in inflammatory diseases. Arthritis Res. 2002, 4: 266-273. 10.1186\/ar419.","journal-title":"Arthritis Res"},{"key":"1019_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/ard.60.8.729","volume":"60","author":"M Cutolo","year":"2001","unstructured":"Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH: Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 729-735. 10.1136\/ard.60.8.729.","journal-title":"Ann Rheum Dis"},{"key":"1019_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199507203330302","volume":"333","author":"JR Kirwan","year":"1995","unstructured":"Kirwan JR: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995, 333: 142-146. 10.1056\/NEJM199507203330302.","journal-title":"N Engl J Med"},{"key":"1019_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.60.1.61","volume":"60","author":"JW Jacobs","year":"2001","unstructured":"Jacobs JW, Geenen R, Evers AW, van Jaarsveld CH, Kraaimaat FW, Bijlsma JW: Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 61-64. 10.1136\/ard.60.1.61.","journal-title":"Ann Rheum Dis"},{"key":"1019_CR21","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","volume":"343","author":"JM Bathon","year":"2000","unstructured":"Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000, 343: 1586-1593. 10.1056\/NEJM200011303432201.","journal-title":"N Engl J Med"},{"key":"1019_CR22","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000, 343: 1594-1602. 10.1056\/NEJM200011303432202.","journal-title":"N Engl J Med"},{"key":"1019_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0076-6879(88)62091-X","volume":"162","author":"PH Wooley","year":"1988","unstructured":"Wooley PH: Collagen-induced arthritis in the mouse. Methods Enzymol. 1988, 162: 361-373.","journal-title":"Methods Enzymol"},{"key":"1019_CR24","first-page":"507","volume-title":"In Arthritis and Allied Conditions","author":"DE Furst","year":"1993","unstructured":"Furst DE, Paulus HE: Aspirin and other non-steroidal anti-inflammatory drugs. In Arthritis and Allied Conditions. Edited by: McCarty D. 1993, Philadelphia: Lea & Febiger, 507-543. 12","edition":"12"},{"key":"1019_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001, 345: 1098-1104. 10.1056\/NEJMoa011110.","journal-title":"N Engl J Med"},{"key":"1019_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/art.10758","volume":"48","author":"NR Slifman","year":"2003","unstructured":"Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM: Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum. 2003, 48: 319-324. 10.1002\/art.10758.","journal-title":"Arthritis Rheum"},{"key":"1019_CR27","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1002\/art.10679","volume":"46","author":"SL Brown","year":"2002","unstructured":"Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM: Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002, 46: 3151-3158. 10.1002\/art.10679.","journal-title":"Arthritis Rheum"},{"key":"1019_CR28","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/art.10583","volume":"46","author":"JH Lee","year":"2002","unstructured":"Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN, Braun MM: Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum. 2002, 46: 2565-2570. 10.1002\/art.10583.","journal-title":"Arthritis Rheum"},{"key":"1019_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.10097","volume":"46","author":"K Redlich","year":"2002","unstructured":"Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Turk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen JS, Schett G: Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 2002, 46: 785-792. 10.1002\/art.10097.","journal-title":"Arthritis Rheum"},{"key":"1019_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2249.1998.00500.x","volume":"111","author":"N Bessis","year":"1998","unstructured":"Bessis N, Chiocchia G, Kollias G, Minty A, Fournier C, Fradelizi D, Boissier MC: Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol. 1998, 111: 391-396. 10.1046\/j.1365-2249.1998.00500.x.","journal-title":"Clin Exp Immunol"},{"key":"1019_CR31","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3","volume":"44","author":"G Schett","year":"2001","unstructured":"Schett G, Hayer S, Tohidast-Akrad M, Schmid BJ, Lang S, Turk B, Kainberger F, Haralambous S, Kollias G, Newby AC, Xu Q, Steiner G, Smolen J: Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum. 2001, 44: 2888-2898. 10.1002\/1529-0131(200112)44:12<2888::AID-ART477>3.0.CO;2-3.","journal-title":"Arthritis Rheum"},{"key":"1019_CR32","first-page":"S15","volume":"46","author":"TF Cruz","year":"1996","unstructured":"Cruz TF, Tang J, Pronost S, Pujol JP: Molecular mechanisms implicated in the inhibition of collagenase expression by diacerheine [in French]. Rev Prat. 1996, 46: S15-S19.","journal-title":"Rev Prat"},{"key":"1019_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0945-053X(02)00028-8","volume":"21","author":"B Dozin","year":"2002","unstructured":"Dozin B, Malpeli M, Camardella L, Cancedda R, Pietrangelo A: Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol. 2002, 21: 449-459. 10.1016\/S0945-053X(02)00028-8.","journal-title":"Matrix Biol"},{"key":"1019_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/joca.2000.0383","volume":"9","author":"T Tamura","year":"2001","unstructured":"Tamura T, Kosaka N, Ishiwa J, Sato T, Nagase H, Ito A: Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes. Osteoarthritis Cartilage. 2001, 9: 257-263. 10.1053\/joca.2000.0383.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/joca.1998.0199","volume":"7","author":"N Felisaz","year":"1999","unstructured":"Felisaz N, Boumediene K, Ghayor C, Herrouin JF, Bogdanowicz P, Galerra P, Pujol JP: Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage. 1999, 7: 255-264. 10.1053\/joca.1998.0199.","journal-title":"Osteoarthritis Cartilage"},{"key":"1019_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0014-2999(02)01898-8","volume":"448","author":"T Tamura","year":"2002","unstructured":"Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N: Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur J Pharmacol. 2002, 448: 81-87. 10.1016\/S0014-2999(02)01898-8.","journal-title":"Eur J Pharmacol"},{"key":"1019_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI2676","volume":"102","author":"L Genestier","year":"1998","unstructured":"Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard JP: Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest. 1998, 102: 322-328.","journal-title":"J Clin Invest"},{"key":"1019_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-065X.1999.tb01315.x","volume":"169","author":"G Kollias","year":"1999","unstructured":"Kollias G, Douni E, Kassiotis G, Kontoyiannis D: On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev. 1999, 169: 175-194.","journal-title":"Immunol Rev"},{"key":"1019_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","volume":"10","author":"D Kontoyiannis","year":"1999","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999, 10: 387-398. 10.1016\/S1074-7613(00)80038-2.","journal-title":"Immunity"},{"key":"1019_CR40","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.4049\/jimmunol.170.9.4793","volume":"170","author":"A Wunder","year":"2003","unstructured":"Wunder A, Muller-Ladner U, Stelzer EH, Funk J, Neumann E, Stehle G, Pap T, Sinn H, Gay S, Fiehn C: Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol. 2003, 170: 4793-4801.","journal-title":"J Immunol"}],"container-title":["Arthritis Res Ther"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar1028\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar1028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:08:02Z","timestamp":1714046882000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar1028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,2]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1186\/ar1028","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,7]]},"assertion":[{"value":"9 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2003","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2003","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R65"}}